Japan, Jan. 21 -- CORSAIR PHARMA INC has got intellectual property rights for 'PRODRUG OF TREPROSTINIL.' Other related details are as follows:
Application Number: JP,2023-181004
Category (FI): A61K45/00,A61K31/341,A61K9/70,401,A61K31/216,A61K31/16,C07C235/20@Z,A61P9/12,A61P11/00,A61K31/365
Stage: Grant (IP right document published.)
Filing Date: Oct. 20, 2023
Publication Date: Jan. 23, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.